Should we be using 5-HT3 antagonists as first line antiemetic therapy in cisplatin-based chemotherapy?
Mansi
J L
JL
Evans
T R
TR
Smith
A
A
Oakley
C
C
Wastnage
R
R
Dalgleish
A
A
D002945:Cisplatin / Q000009:adverse effects*; D003907:Dexamethasone / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006801:Humans; D017294:Ondansetron / Q000008:administration & dosage; D012702:Serotonin Antagonists / Q000627:therapeutic use*; D014839:Vomiting / Q000139:chemically induced / Q000517:prevention & control*
D012702:Serotonin Antagonists; D017294:Ondansetron; D003907:Dexamethasone; D002945:Cisplatin